PCN38 WITHIN COUNTRY DIFFERENCES IN MAMMOGRAPHY COVERAGE OF THE HUNGARIAN NATIONWIDE ORGANIZED BREAST CANCER SCREENING PROGRAMME
University of Pécs, Pécs, Hungary OBJECTIVES: Nationwide organized breast cancer screening programme was launched 2002 in Hungary for women between the age of 45-65 with a 2 years screening interval. The aim of the study is to analyse the within country inequalities of mammography coverage of the organized programme. METHODS: Data derive from the database of the National Health Insurance Fund Administration (OEP) containing routinely collected financial data. The study includes all the women aged 45-64 having either screening or diagnostic mammography before (2000) (2001) and after (2002-2003 and 2004-2005 ) the introduction of organized screening. The regional inequalities are calculated for 19 counties and Budapest as the capital (altogether 20 items). Coverage is defined as the proportion of women resident who have had a mammogram at least once in the previous 2 years. RESULTS: National mammography coverage was 26. 7%, 54,6% and 51,6% in 2000-2001, 2002-2003 and 2004-2005 4 (2004-2005) . CONCLUSION: We found significant within country differences in mammography coverage, however the gap between counties with lowest and highest coverage became smaller after the introduction of organized screening programme. . We found that in the age-group 65-74 there is a balance between the cost distribution (20.9% and 20.2%) and the deaths (22.8%). Women in younger age groups received more treatment cost than its mortality would predict, while in older age groups (75+)-responsible 35.2% of deaths-received only 7.4% and 8.7% of out-and inpatient treatment cost respectively. CONCLUSION: There is a shift between the distribution of treatment cost of and deaths due to breast cancer in favor of younger age-groups. Evidence guiding NSCLC treatment has been derived largely from controlled trials at academic centers. Much less attention has focused on understanding NSCLC treatment by community-based oncologists. We undertook this study to better understand NSCLC treatment patterns and outcomes in community-based practices. METHODS: Ten large communitybased oncology practices in the U.S. were identified. Investigators conducted chart reviews on 417 NSCLC patients treated with chemotherapy between 2001 and 2003 who were deceased at the time of the review. RESULTS: Of the 417 patients (54% male, median age 68 years, mean performance status 1.2) almost 20% had a history of radiation therapy, and 9.6% had a history of surgery. Mean survival was 10.5 months for stage IIIB patients (n = 114) and 7.9 months for stage IV patients (n = 303). In their first line of chemotherapy, 55% of patients received both carboplatin and paclitaxel (18% in combination with radiation therapy). Another 11% received carboplatin with either gemcitabine (6%) or doctaxel (5%). In contrast, monotherapy was more common in second line therapy (docetaxel 22%, gemc-
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